abstract |
Compositions for sensitizing tumors to anti-tumor therapies are provided herein. The composition comprises an antisense oligonucleotide against TGF [beta] 2, wherein these compositions sensitize the tumor to anti-tumor therapy. Methods for treating cancer using the compositions described herein are also provided herein. |